Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Orexigen developed Contrave® (naltrexone HCl and bupropion HCl extended release), which is approved in the United States and is being commercialized there by the company's North American partner, Takeda Pharmaceuticals.

from http://www.orexigen.com/about-orexigen.html

Patents 335show all

  • 111
    A61K - Preparations for medical, dental, or toilet purposes

Clinical Trials 19show all

8Phase 26Phase 33Phase 12Phase 4

SEC Filings show all


207
8-K

33
10-Q

10
10-K

3
D

1
S-1

Contact Information

San Diego, CA
United States